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T Cell-Specific Loss of Pten Leads to Defects
in Central and Peripheral Tolerance
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Summary
cytes (Teh et al., 1988; Kaye et al., 1989). Self-reactive
T cells that escape into the periphery are controlled
PTEN, a tumor suppressor gene, is essential for em-
by mechanisms of peripheral tolerance, such as clonalbryogenesis. We used the Cre-loxP system to generate
deletion and functional inactivation (Webb et al., 1990).a T cell-specific deletion of the Pten gene (Ptenflox/2
Despite intensive study (reviewed by Sebzda et al.,mice). All Ptenflox/2 mice develop CD41 T cell lympho-
1999), the complex signaling pathways underlying themas by 17 weeks. Ptenflox/2 mice show increased thy-
establishment of central and peripheral tolerance remainmic cellularity due in part to a defect in thymic negative
incompletely defined.selection. Ptenflox/2 mice exhibit elevated levels of B
To investigate the role of Pten in T cell tolerance, wecells and CD41 T cells in the periphery, spontaneous
used the Cre-loxP conditional gene targeting system toactivation of CD41 T cells, autoantibody production,
generate mice in which Pten was disrupted in T cells.and hypergammaglobulinemia. Ptenflox/2 T cells hyper-
We describe the phenotype of Lck-CrePtenflox/2 mice andproliferate, are autoreactive, secrete increased levels
report results revealing possible mechanisms contribut-of Th1/Th2 cytokines, resist apoptosis, and show in-
ing to the autoimmunity and tumorigenesis observed increased phosphorylation of PKB/Akt and ERK. Periph-
Pten-deficient mice.eral tolerance to SEB is also impaired in Ptenflox/2 mice.
PTEN is thus an important regulator of T cell homeo-
Resultsstasis and self-tolerance.
Generation of T Cell-Specific Pten-Deficient MiceIntroduction
T cell-specific Pten-deficient mice (Lck-CrePtenflox/2;
Ptenflox/2) were generated using the strategy described inMutations of the tumor suppressor gene PTEN (also
called MMAC1 or TEP1) (Li et al., 1997) have been identi- Figure 1A and Experimental Procedures. Ptenflox/2 mice
were born alive and appeared healthy. Genomic South-
ern blotting showed that, in the vast majority of thymo-8 Correspondence: tnakano@biken.osaka-u.ac.jp
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Figure 1. T Cell-Specific Gene Targeting and Altered Cell Populations in Lymphoid Organs of Pten flox/2 Mice
(A) Construction of the targeting vector and mutant alleles. (Aa) Genomic structure of the mouse Pten gene. A, ApaI; E, EcoRI; H, HindIII. (Ab)
The targeting vector. Exons 4 and 5 were flanked by two loxP sequences, shown as black arrowheads. A third loxP sequence was introduced
to flank the Hygr gene. (Ac) The mutated allele containing three loxP sequences and the Hygr gene. Cre-mediated deletion was expected to
produce the (Ad) Ptenflox allele and (Ae) PtenD allele.
(B) Southern blot analysis. DNA (20 mg) was extracted from thymocytes of mice of the indicated genotypes. Blots were hybridized to the
probe indicated in Figure 1Aa. wt, wild-type.
(C) Western blot analysis of proteins from thymocytes of mice of the indicated genotypes.
(D) Absolute numbers of DN, DP, CD41, CD81, and B2201 cells in the thymus (Thy), mesenteric lymph nodes (MLN), and spleen (SP).
(E) CD4/CD8 ratio in the thymus, MLN, and spleen.
(D and E) The results are expressed as the mean 6 SEM for six mice of 6–8 weeks of age per group. 1/1, Lck-CrePten1/1 mice; flox/2, Lck-
CrePtenflox/2 mice. Statistical differences were determined using the Student’s t test; *, p , 0.05.
(F) CD69 expression in the thymus and in CD41 and CD81 populations of MLN (LN/CD41 and LN/CD81) of the mice analyzed in (D).
cytes, the loxP sites and the DNA between them in the the mesenteric lymph nodes (MLN), spleen, and thymus
were examined. Total numbers of splenocytes, MLN6.0 kb Ptenflox allele had been deleted, generating the
2.3 kb PtenD allele (Figure 1B). The deletion of Pten cells, and thymocytes were increased in Ptenflox/2 mice
2.0-fold, 1.5-fold, and 2.2-fold, respectively (Figure 1D).exons 4 and 5 was confirmed at the protein level by
Western blotting using antibody recognizing the N termi- No tumor formation was observed either macro- or mi-
croscopically at this stage. Flow cytometric analysis re-nus of Pten (Figure 1C).
vealed that the total numbers of double-negative (DN;
CD42CD82), double-positive (DP; CD41CD81), andLymphadenopathy, Splenomegaly, and Enlarged
Thymi in Ptenflox/2 Mice CD41 single-positive (SP) cells were increased in the
thymus from Ptenflox/2 mice. In the periphery, the totalLck-CrePten1/1 (Pten1/1) and Ptenflox/2 mice were sacri-
ficed at 6–8 weeks of age, and T cell subpopulations in numbers of CD41 and B2201 cells were increased, but
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the number of CD81 cells was about normal (Figure 1D). TCR (Table 1 and Figure 3A). However, the total number
of thymic DP cells as well as the number of thymic DPA greater expansion or accumulation of CD41 T cells in
the spleen than in the MLN led to a higher CD4/CD8 cells which expressed the Tg TCR was more than 10-
fold greater in male HYLck-CrePtenflox/2 mice than inratio in this organ (Figure 1E). Immunostaining to detect
the T cell activation marker CD69 showed that Ptenflox/2 male HYLck-CrePten1/1 mice, as detected by a clono-
typic mAb specific for the Vb8.2 chain (data not shown)thymocytes and peripheral T cells were spontaneously
activated, peripheral CD41 cells more so than CD81 or the T3.70 mAb specific for the transgenic Va chain
(Figure 3A and Table 1). These data indicate that HY-cells (Figure 1F). Surface staining of B cells in bone
marrow and spleen of Ptenflox/2 mice showed that the TCR Ptenflox/2 mice have a defect in thymic negative
selection. It should be noted, however, that thymocytetotal numbers of pro-B, pre-B, and mature B cells were
all increased proportionately (data not shown). No differ- numbers in HYLck-CrePtenflox/2 male mice were only re-
duced z2-fold compared to numbers in the thymi ofences from the wild-type (wt) were observed in CD40
expression on B cells, or in CD40L, TCRab, CD28, or positively selecting HYLck-CrePtenflox/2 female mice.
Histological comparison of tissues of 8- to 9-week-oldCD25 expression on T cells, in either splenic or MLN
cell populations (data not shown). male HYLck-CrePtenflox/2, HYLck-CrePten1/1, and Lck-
CrePtenflox/2 mice (not transgenic for the HY-TCR)
showed a marked infiltration of small lymphoid cells intoPremature Death of Ptenflox/2 Mice Due
both perivascular areas and some alveolar septa of theto CD41 T Cell Lymphomas
lungs of all three male HYLck-CrePtenflox/2 mice exam-To determine the impact on the whole animal of the T
ined (Figure 3B). Atypical cells were not detected, sug-cell-specific Pten mutation, the health and development
gesting the occurrence of “lymphoid interstitial pneumo-of 16 Ptenflox/2, 20 Pten1/2, and 20 Pten1/1 mice were
nia,” a disorder thought to be caused by autoimmunemonitored over a period of 1 year. Tumor formation was
mechanisms (Staszak and Harbeck, 1985). No histologi-observed from 10 weeks of age (Figure 2A), and all 16
cal alterations were observed in four HYLck-CrePten1/1Ptenflox/2 mice died of malignant T cell lymphomas within
male or three Lck-CrePtenflox/2 male mice.17 weeks (Figure 2B), exhibiting enlarged lymph nodes,
Positively selecting female HYLck-CrePten1/1 micespleen, thymus, and liver. Histologically, the lymphomas
showed a substantial increase in the CD81 SP popula-appeared as sheets of relatively homogeneous cells
tion in the thymus compared to female Lck-CrePten1/1mixed with scattered tingible body macrophages to give
mice, consistent with the recognition of MHC classa “starry-sky” appearance (Figure 2C). The lymphoma
I by the HY-TCR transgene. An z2-fold decrease bothcells had scant cytoplasm, enlarged round nuclei, irreg-
in the number of transgenic CD81 SP cells (Figures 3Cular nuclear contours, and prominent nucleoli (Figure
and 3D) and the CD8/CD4 ratio was observed in female2D) compared to wt cells (Figure 2E). A massive invasion
HYLck-CrePtenflox/2 mice compared to female HYLck-of lymphocytes occurred adjacent to the blood vessels
CrePten1/1 mice, while the number of transgenic CD41in other tissues, such as liver (Figure 2F), kidney (Figure
2G), and lung (Figure 2H). Pten1/2 mice, especially the SP cells was increased 1.5-fold. These results suggest
that HYLck-CrePtenflox/2 mice are also impaired in thefemales, began to show polyclonal lymphoid hyperpla-
sia at 28 weeks, and 50% of these mice died within 1 year positive selection of CD81 cells in the thymus and that
the DP precursor cells may be preferentially developingof birth. No Pten1/1 mouse developed tumors during the
12 month observation period. About 90% of the T cell into CD41 cells. This is consistent with the increase in
CD41 SP cells in the HYLck-CrePtenflox/2 male mice.tumors in Ptenflox/2 mice could be classified as CD41 SP
T cell lymphomas (Figure 2I), and 10% were a mixture Taken together, our data suggest that Pten influences
both lineage commitment and negative thymic se-of CD41 SP and DP lymphomas. CD81 SP T cell lympho-
mas were never observed. Monoclonality of invading lection.
lymphoma cells was detected in 12% of affected mice,
using four antibodies reactive to specific TCR variable Superantigen-Induced Deletion of Peripheral T Cells
regions (Figure 2J). Peripheral tolerance was investigated using deletion of
peripheral T cells induced by the superantigen staphylo-
coccal enterotoxin B (SEB). SEB specifically recognizesImpaired Negative Thymic Selection
in Pten-Deficient HY-TCR TCRs containing Vb8, such that Vb81 peripheral T cells
expand and are subsequently deleted in an animal in-Transgenic Mice
To investigate the role of Pten in central tolerance, we jected with SEB (Kawabe and Ochi, 1991). As shown in
Figure 3F, a single dose of SEB injected into the perito-crossed the Lck-CrePtenflox/2 mutation into HY-TCR
transgenic (Tg) animals (C57BL/6J background; H-2b; neal cavity of a Pten1/1 mouse induced an expansion
of Vb81CD41 T cells that peaked on day 2 postinjection,Kisielow et al., 1988) to generate HYLck-CrePtenflox/2
mice. The majority of thymocytes in HY-TCR Tg mice followed by deletion of this population by day 7. Vb81
T cells from Ptenflox/2 mice expanded to almost the samebear TCRs specific for the male antigen HY, such that
they are positively selected in female mice but negatively degree as those from Pten1/1 mice but were resistant to
deletion and had not declined below preinjection levelsselected in male mice of the H-2b background. Positive
and negative selection in the thymus were compared in even by day 14 (Figure 3E). Control Vb61CD41 peripheral
T cells, whose TCRs are not recognized by SEB, failedHYLck-CrePten1/1 and HYLck-CrePtenflox/2 mice. Con-
sistent with published reports (Kisielow et al., 1988), to undergo deletion (Figure 3F). SEB-induced peripheral
deletion is thus impaired in the absence of Pten, sug-negatively selecting male HYLck-CrePten1/1 mice
showed a marked reduction in total thymocyte numbers gesting that Pten is involved in the establishment of
peripheral tolerance.as well as a decrease in DP cells expressing the HY Tg
Immunity
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Figure 2. Spontaneous Development of CD41 T Cell Lymphomas
(A) Ptenflox/2 mice develop lymphomas with massive hepatolymphoid organomegaly (right panel). Left panel shows the same organs in a control
Pten1/1 mouse.
(B) Survival curve of Ptenflox/2 mice compared to wild-type (1/1) and heterozygous (1/2) mice.
(C–H) Histology. Mesenteric lymph node of a lymphoma-bearing Ptenflox/2 mouse (C), lymphoma cells in the spleen of a Ptenflox/2 mouse (D),
and the spleen of a wild-type mouse (E); bar represents 30 mm. Infiltrate (red arrow) in liver (F), kidney (G), and lung (H) of a Ptenflox/2 mouse.
(I) Flow cytometric profile of CD4/CD8 staining of the enlarged lymph node of an Lck-CrePtenflox/2 mouse.
(J) TCR Vb8 staining of CD41 cells from the enlarged lymph node analyzed in (I). MLN CD41 cells from a Pten1/1 mouse were used as a
control.
Autoreactivity of Pten-Deficient T Cells neic C57BL6/J mice (Figure 4A, left) or allogeneic DBA1
mice (Figure 4A, right) were cocultured with Pten1/1 orTo determine whether T cells in Ptenflox/2 mice were auto-
reactive, mixed lymphocyte reactions (MLR) were per- Ptenflox/2 T cells (responders) from 6- to 8-week-old mice,
and proliferation was assayed by [3H]thymidine uptake.formed. Irradiated splenocytes (stimulators) from synge-
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Table 1. Profile of HY-TCR Transgenic Model
Male Female
Tg2Pten1/1 Tg1Pten1/1 Tg1Pten1/1 Tg1Pten1/1 Tg1Ptenflox/2 Tg1Ptenflox/2 Tg1Ptenflox/2 Tg1Pten1/1 Tg1Ptenflox/2
Thymus (3 106) 135 16 17 21 110 75 53 140 190
CD41CD81 (%) 76 9.3 4.9 11 35 61 32 58 66
CD41CD81 (3 106) 100 1.5 0.81 2.2 38 46 17 84 130
T3.70 (%) — 67 49 51 58 48 40 26 21
T3.70 (3 106) — 11 8.0 11 64 36 21 36 40
Spleen (3 106) 110 120 150 100 210 450 345 — —
T3.70 (3 106) — 50 53 25 95 142 94 — —
Total thymocytes and spleen cells were isolated from the HYLck-CrePten1/1 and HYLck-CrePtenflox/2 mice in negative-selecting (male, H-2b)
and positive-selecting backgrounds (female, H-2b) and control Pten1/1 mice. All mice were aged matched. Cells were stained simultaneously
with anti-CD8 (FITC), anti-CD4 (PE), and T3.70 antibody (biotin), which recognizes the transgenic TCR Va chain. T3.70 antibody was visualized
using streptoavidin-Red 670. Samples were analyzed using a FACSCalibur.
Interestingly, the already enhanced proliferative capac- serum IgG1 and the increased B cell number observed
ity of Ptenflox/2 T cells was further increased when the in Ptenflox/2 mice. Our data show that loss of Pten in T
cells were cocultured not only with the allogeneic stimu- cells results in increased proliferation and enhanced
lators but also the syngeneic stimulators, indicating that cytokine production of Th1 and Th2 cytokines.
Ptenflox/2 T cells are autoreactive.
To investigate whether the loss of Pten in T cells also
affected self-tolerance in the humoral response, serum Decreased Apoptosis of Ptenflox/2 Thymocytes
Ig levels and autoantibody titers were assessed in Ptenflox/2 and Peripheral T Cells In Vitro
mice of 6–8 weeks of age. Levels of IgG1, IgG2b, IgM, To determine whether the loss of self-tolerance in Pten-
and IgA were elevated in Pten1/2 mice compared to deficient mice could be partially due to a defect in thy-
Pten1/1 mice (Figure 4B), and the level of IgG1 was mocyte apoptosis, we evaluated the responses of Ptenflox/2
increased still further in Ptenflox/2 mice. Serum anti- thymocytes to treatment in vitro with various apoptotic
ssDNA Ab were measured at 6–8 weeks (Figure 4C, left) stimuli as described in Figure 5C. Loss of Pten conferred
and 6–8 months (Figure 4C, right). Pten1/2 mice of 6–8 resistance to apoptosis, particularly to cell death in-
months of age, especially those exhibiting lymphoid hy- duced by the specific adenosine receptor agonists N6-
perplasia, produced significantly greater amounts of [4-[[[4-[[[(2-aminoethyl)amino]carbonyl]methyl]-anilino]
anti-ssDNA Ab compared to Pten1/1 mice. Ptenflox/2 mice carbonyl]methyl]phenyl]adenosine (ADAC, RBI; Figure
died before 6 months of age, but titers of anti-ssDNA 5CH) and 2-p-(2-carboxyethyl)phenethylamino-59-N-
Ab in 6- to 8-week-old Ptenflox/2 mice were higher than ethylcar-boxamidoadenosine hydrochloride (CGS-21680,
those of Pten1/1 or Pten1/2 mice of the same age. Inter- Sigma; Figure 5CI) (Sasaki et al., 2000). A more modest
estingly, this titer was still lower than that of 6- to but still significant antiapoptotic effect was obtained
8-month-old Pten1/2 mice with lymphoid hyperplasia. when Ptenflox/2 thymocytes were stimulated with g irradi-
Taken together, our data suggest that Pten is required ation or UV (Figures 5CF and 5CG, respectively). No
for normal self-tolerance in both the humoral and cell- statistically significant differences in apoptosis were
mediated branches of the immune response. observed following treatment with anti-CD3e, dexa-
methasone, adriamycin, anti-Fas antibody, or serum
withdrawal (Figures 5CA, 5CB, 5CC, 5CD, and 5CE, re-Enhanced Proliferation and Cytokine
spectively).Production of Ptenflox/2 T Cells
To determine whether Pten influences peripheral TTo examine the function of peripheral T cells in Ptenflox/2
cell survival, peripheral T cells were treated in vitro withmice, purified MLN T cells were stimulated in vitro with
a variety of apoptotic stimuli as described in Figurethe stimuli indicated in Figure 5A. Whereas Pten1/1 and
5D (left). A moderate antiapoptotic effect was obtainedPtenflox/2 T cells proliferated equally well in response
when Ptenflox/2 T cells were stimulated with anti-Fas Abto PMA plus Ca21-ionophore, Ptenflox/2 T cells showed
(Figure 5DA), g irradiation (Figures 5DB and 5DC), orenhanced proliferation in response to anti-CD3e, ConA,
UV (low levels; Figure 5DD). No significant differencesor IL-2 stimulation. Addition of anti-CD28 or IL-2 to anti-
between Ptenflox/2 and Pten1/1 cells were observed inCD3e synergistically increased the proliferation of
apoptotic responses to anti-CD3e mAb or adriamycinPten1/1, Pten1/2, and Ptenflox/2 T cells. Cytokine produc-
(Figures 5DF and 5DG, respectively). However, dramatiction by purified MLN T cells stimulated with anti-CD3e
resistance to apoptosis was observed in Ptenflox/2 T cellsplus anti-CD28 mAbs or ConA was measured using
from which IL-2 or IL-2 plus serum were withdrawn (Fig-ELISA. Activated Ptenflox/2 T cells produced significantly
ures 5DH and 5DI, respectively). By 48 hr after with-higher levels of both Th1 (IL-2 and IFNg) and Th2 (IL-4,
drawal of IL-2, only 46% of Pten1/1 T cells remainedIL-6, and IL-10) cytokines compared to Pten1/2 or
viable, compared to 98% of Ptenflox/2 cells (Figure 5D,Pten1/1 cells (Figure 5B). This increase in IL-10 and IL-4,
right). These results indicate that loss of Pten preventscytokines that favor immunoglobulin class switching to
T cells from initiating apoptosis in response to severalIgG1 (Briere et al., 1994; Esser and Radbruch, 1989),
may at least partially account for the enhanced level of stimuli, including some known to be mutagenic.
Immunity
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Figure 3. Altered Central and Peripheral Tolerance in Ptenflox/2 Mice
(A and B) Impaired thymic negative selection in Pten-deficient HY-TCR transgenic mice.
(A) Thymocytes from 8-week-old Lck-CrePtenflox/2 (n 5 8) and Lck-CrePten1/1 (n 5 6) HY-TCR Tg mice in a negatively selecting background
(H-2b, male) were triple stained with anti-CD4-FITC, anti-CD8-PE, and T3.70-biotin mAb, and flow cytometric analysis was performed. Represen-
tative CD4 and CD8 profiles gated on T3.701 thymocytes. Numbers within the panels indicate the relative percentages of positively stained
cells in the gated sample. Total numbers of T3.701CD41CD81 thymocytes for one representative experiment are shown.
(B) Lymphoid interstitial pneumonia in the lung of a male HYLckCrePtenflox/2 mouse (right). Lung from a male HYLck-CrePten1/1 mouse as a
control (left). Small lymphocytes (arrow) have infiltrated into the perivascular areas and some alveolar septa. B, bronchus; V, blood vessels.
(C and D) Altered thymic positive selection in Pten-deficient HY-TCR transgenic mice. Thymocytes from 8-week-old Lck-CrePtenflox/2 (n 5 5)
and Lck-CrePten1/1 (n 5 8) HY-TCR Tg mice in a positively selecting background (H-2b, female) were triple stained with anti-CD4-FITC, anti-
CD8-PE, and T3.70-biotin mAb.
(C) Total numbers of CD81, DP, and CD41 cells in T3.701 thymocytes.
(D) Representative CD4 and CD8 profiles gated on T3.701 thymocytes (upper panel); proportion of T3.701 cells in total thymocytes (second
panel), in CD41 SP thymocytes (third panel), and in CD81 SP thymocytes (lower panel). Numbers within panels indicate the relative percentages
of positively stained cells in the gated sample.
Loss of Pten Leads to Defects in Self-Tolerance
529
Figure 4. Autoreactivity of Pten-Deficient T Cells
(A) MLR. Responder T cells from Ptenflox/2 or Pten1/1 mice were incubated with stimulator T cells from syngeneic C57BL/6J (left) or allogeneic
DBA1 (right) mice. Proliferation was measured as mean thymidine uptake (cpm) 6 SEM for three mice per group. Statistical differences were
determined using the Student’s t test; *, p , 0.05.
(B) Concentration of mean serum Ig levels in 6- to 8-week-old Pten1/1 (n 5 8), Pten1/2 (n 5 6), and Ptenflox/2 (n 5 8) mice as determined by
ELISA. Statistical differences were measured using the Welch’s test. *, p , 0.05.
(C) Concentration of serum anti-ssDNA autoantibodies in 6- to 8-week-old mice (left panel) and 6- to 8-month-old mice (right panel) as
determined by ELISA. Left panel (from left to right): Pten1/1 (n 5 3), Pten1/2 (n 5 3), and Ptenflox/2 (n 5 3) mice. Right panel (from left to right):
Pten1/1 (n 5 3), Pten1/2 mice without lymphoid hyperplasia (n 5 6), Pten1/2 mice with lymphoid hyperplasia (n 5 6), and positive control MRL/
lpr mice (n 5 3) of 4–6 months of age. Results are shown as the mean 6 SEM.
Expression of Molecules Downstream 1999), phospho-p38 (Sugawara et al., 1998), p27KIP (Li
and Sun, 1998), or phospho-BAD (Datta et al., 1997; delof Pten in Ptenflox/2 T Cells
To identify molecules that might be responsible for the Peso et al., 1997) (Figure 6C and data not shown). Our
results suggest that at least some of the phenotypes ofphenotypes of the Ptenflox/2 mice, the expression of vari-
ous candidate proteins potentially acting downstream Lck-CrePtenflox/2 mice maybe caused by disregulated
PKB/Akt and ERK activation.of Pten was analyzed by immunoblotting. We have pre-
viously reported that regulation of PKB/Akt activation
by Pten is critical for normal apoptosis in embryonic Discussion
fibroblasts (Stambolic et al., 1998) and possibly for on-
cogenesis. We therefore analyzed the phosphorylation In this study, we have described a novel system for
evaluating the role of the multifunctional phosphataseof PKB/Akt in Ptenflox/2 peripheral T cells. Following stim-
ulation with anti-CD3e and anti-CD28 mAbs and/or IL-2, Pten in murine T cell development and function. The
Cre-loxP system was used to generate a T cell-specificthe phosphorylation of PKB/Akt was reproducibly ele-
vated in Ptenflox/2 peripheral T cells compared to Pten1/1 mutation of Pten in mice, and defects of central and
peripheral T cell tolerance were identified. Our data arecells (Figure 6A). Importantly, the increase in PKB/Akt
phosphorylation was paralleled by an increase in PKB/ highly relevant in the context of investigating whether
PTEN links autoimmunity and tumorigenesis.Akt kinase activity in Ptenflox/2 T cells relative to controls
(Figure 6B). Increases in ERK phosphorylation (Gu et al.,
1998) and Bcl-XL expression (Jones et al., 2000) were Roles for Pten in Thymic and Peripheral Tolerance
We have demonstrated, using the HY-TCR transgenicalso consistently observed, although no reproducible
differences were found in the expression levels of candi- system, that there is a modest but definite defect in
thymic negative selection in Ptenflox/2 mice. However,date signaling molecules such as IkBa (Romashkova
and Makarov, 1999; Ozes et al., 1999; Jones et al., 2000), repeated experiments failed to reveal a difference
in anti-CD3 mAb-induced apoptosis of Pten1/1 andBcl-2 (Pugazhenthi et al., 2000), c-myc (Ghosh et al.,
(E and F) Impaired peripheral tolerance following SEB injection in vivo. Pten1/1 (n 5 12), Pten1/2 (n 5 8), and Ptenflox/2 (n 5 7) mice were
injected i.p. with SEB on day 0. Peripheral blood cells were stained with anti-Vb8.1/8.2-FITC and anti-CD4-PE (E) or with anti-Vb6-FITC and
anti-CD4-PE (F) and analyzed by flow cytometry as indicated. Results are expressed as the mean 6 SEM. Statistical differences were
determined using the Welch’s test; *, p , 0.05.
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Figure 5. Increased Proliferation and cytokine Production but Defective Induction of Apoptosis in Pten-Deficient Thymocytes and Peripheral
T Cells
(A–D) Statistical differences were determined using the Student’s t test; *, p , 0.05.
(A) Enhanced proliferation of MLN T cells. Purified MLN T cells from 6-week-old Pten1/1, Pten1/2, and Ptenflox/2 mice were incubated with the
indicated stimuli, and proliferation was measured by thymidine uptake. Mean thymidine uptake 6 SEM for three mice per group is shown.
(B) Enhanced cytokine production by Pten-deficient T cells. Supernatants of cultures of purified splenic T cells stimulated with anti-CD3e plus
anti-CD28 mAbs or ConA for 30 hr were assayed by ELISA for the production of IL-2, IFNg, IL-4, IL-6, and IL-10 as indicated. Results shown
are the mean 6 SEM for three mice per group. No, no stimulus; nd, not detected.
(C) Thymocyte apoptosis. Thymocytes from 6-week-old mice were stimulated for 24 hr with immobilized anti-CD3e (10 mg/ml [CA]), dexametha-
zone (0.01 M [CB]), adriamycin (0.2 mg/ml [CC]), anti-Fas (1 mg/ml [CD]), g irradiation (1 Gy [CF]), UV irradiation (3 J/m2 [CG]), or for 48 hr with
serum withdrawal (CE) or the adenosine receptor agonists ADAC (10 mM [CH]) or CGS-21680 (10 mM [CI]). Cell viability was determined by
7-AAD or Annexin V-PI staining followed by flow cytometry. The percentage of viable cells remaining after treatment as compared with the
viability of untreated cells cultured for the same length of time is shown. Results are expressed as the mean 6 SEM for nine mice per group.
(D) AICD of peripheral T cells. (Left panel) Splenic T cells were activated for 48 hr with anti-CD3e and rIL-2 prior to treatment with apoptotic
stimuli as follows: anti-Fas (1 mg/ml [DA]), g irradiation (3 Gy [DB] and 10 Gy [DC]), UV irradiation (5 J/m2 [DD] and 30 J/m2 [DE]), anti-CD3e
(10 mg/ml [DF]), adriamycin (0.2 mg/ml [DG]), withdrawal of IL-2 alone (DH), or withdrawal of both IL-2 and serum (DI). Cell viability was
determined as in Figure 5C. (Right panel) Time course of cell viability after cells were subjected to withdrawal of IL-2 and/or serum as indicated.
The results are expressed as the percentage of viable cells remaining compared to untreated cells cultured with IL-2 for the same length
of time.
Ptenflox/2 T cells. Alteration in thymic negative selection increase in CD41 cells at the expense of CD81 cells.
For example, a reduction in Notch 1 expression canmay thus involve a survival pathway other than that
triggered by TCR signaling. Alternatively, stimulation by induce CD81 cells to differentiate into CD41 cells (Yama-
moto et al., 2000). However, no differences in Notchanti-CD3 in vitro may not fully replicate TCR engagement
in vivo. 1 expression were observed in Pten1/1 and Ptenflox/2
thymocytes and peripheral T cells (data not shown).HY-TCR Tg Ptenflox/2 mice also showed impaired matu-
ration of CD81 cells, which may explain why the numbers Similarly, mice deficient for the T cell activation molecule
Itk have normal numbers of T cells but display a markedof CD81 T cells do not increase in the absence of Pten,
even though Pten deficiency results in the expansion reduction in the CD41 subset (Liao and Littman, 1995).
Itk-deficient T cells also show decreased proliferationof all other T cell subpopulations in the thymus and
peripheral lymphoid organs. A defect in lineage commit- in response to TCR engagement. Pten deficiency has
been shown to result in constitutive tyrosine phosphory-ment rather than positive selection could lead to an
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Figure 6. Increased Phosphorylation of PKB/Akt and ERK in Ptenflox/2 T Cells in Response to TCR Stimulation
Whole-cell lysates were extracted from purified Pten1/1 and Ptenflox/2 peripheral T cells from 6-week-old mice. Cells were stimulated with
immobilized anti-CD3e and anti-CD28 (A and B) or anti-CD3e and anti-CD28 plus IL-2 (C) for the indicated times. (A) (Upper panel) Western
blot of the expression of phospho-PKB/Akt and PKB/Akt (control) in 20 mg extract protein. (Lower panel) Densitometric quantitation of phospho-
PKB/Akt levels relative to total cellular PKB/Akt. (B) (Left panel) PKB/Akt kinase activity using pGSK-3 fusion protein as substrate. (Right
panel) Densitometric quantitation of phosphoGSK-3 levels relative to controls. (C) Western blots of expression of pERK, IkBa, Bcl-XL, and
actin in 30 mg extract protein. The data are representative of three to seven independent experiments.
lation of Itk and permanent localization of this molecule Molecules Contributing to the Phenotype
of Ptenflox/2 T Cellsin the plasma membrane (Shan et al., 2000). A prominent
signaling molecule downstream of Itk is ERK, known to PTEN influences intracellular signaling via the PIP3 path-
way. We have recently generated mice deficient for an-influence CD4/CD8 commitment. Development of CD41
cells is increased when ERK activity is increased, while other key component of the PIP3 pathway, the p110g
catalytic subunit of phosphoinositide-3-kinase g (PI3Kg)that of CD81 cells is increased when ERK is decreased
(Sharp and Hedrick, 1999). It is possible that the defi- (Sasaki et al., 2000). Several lines of evidence suggest
that p110g deficiency and Pten deficiency have oppositeciency of Pten in T cells of our mutant mice leads to
increased ERK signaling, biasing T cell differentiation effects. Unlike Pten2/2 mice, p110g-deficient mice are
viable, exhibiting decreased numbers of splenic CD41toward CD41 and away from CD81. Such a scenario
might account for the accumulation of CD41 cells in SP cells. Proliferation of p110g2/2 T cells is reduced in
response to all stimuli tested (except PMA 1 Ca iono-Ptenflox/2 mice.
In vivo SEB injection revealed that peripheral toler- phore), and p110g2/2 thymocytes are more susceptible
to apoptotic stimuli, such as ADAC and CGS. Interest-ance was also impaired in Ptenflox/2 mice. Fas signaling
is reportedly involved in SEB-induced tolerance (Kim et ingly, deficiency for the PI3K regulatory subunit p85a
leads to a partial block in early B cell development, butal., 1991), and a defect in Fas signaling has been pro-
posed as the basis of autoimmunity in Pten1/2 mice (Di T cell development is not impaired (Suzuki et al., 1999;
Fruman et al., 1999). A p65PI3K transgenic mouse wasCristofano et al., 1999). However, in our hands, while
Vb81CD41 cells from C57BL/6-lpr/lpr mice resist dele- recently described (Borlado et al., 2000) that expresses
a constitutively active truncated form of p85a in T cellstion compared to Vb81CD41 cells from C57BL/6 mice,
a marked reduction in cell numbers compared to the and exhibits phenotypes very similar to those of Ptenflox/2
mice. Lymphoproliferation and autoimmune diseasepreinjection level is still observed (data not shown). In
contrast, numbers of Vb81CD41 cells from Ptenflox/2 mice characterized by an increased number of T cells, partic-
ularly CD41 cells, were observed in p65PI3K Tg mice.were never significantly reduced compared to the prein-
jection level. These data suggest that the impairment in Furthermore, these animals develop early T cell lympho-
mas when crossed into a p532/2 background. A compari-peripheral tolerance in Ptenflox/2 mice may be due to
more than just a defect in Fas signaling. Experiments son of the phenotypes of p110g2/2, p65PI3K Tg, and Ptenflox/2
mice suggests that the abnormalities in Ptenflox/2 miceto compare SEB-induced deletion in Ptenflox/2 and lpr/lpr
mice of identical genetic background and in Pten/lpr are likely due to hyperactivation of the PIP3 pathway.
Numerous studies have demonstrated inappropriatedouble mutant mice are in progress.
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Not only was Cre-mediated deletion of exons 4 and 5 expected toactivation of PKB/Akt in Pten-deficient tumor cells (Su-
inactivate Pten function, but the deletion also caused a frame shift,zuki et al., 1998; Haas-Kogan et al., 1998), pointing to
completely disrupting the rest of the protein coding sequence.an important role for PKB/Akt in oncogenesis. While
activation of PKB/Akt and Bcl-XL was increased in stimu- Generation of Lck-CrePtenflox/2 and HY-TCR Tg
lated Ptenflox/2 T cells compared to controls, levels of Lck-CrePtenflox/2 Mice
the downstream molecule IkBa were not altered. It may The linearized targeting vector was electroporated into E14K embry-
be that the modest activation of PKB/Akt induced in the onic stem (ES) cells (H-2b haplotype). Selection of targeted clones
was carried out in 150 mg/ml hygromycin. Hygromycin-resistantabsence of Pten in T cells is insufficient to induce the
clones were screened for homologous recombination by PCR fol-degradation of IkBa. Transgenic mice in which PKB/Akt
lowing identification by genomic Southern blot as shown in Figureis constitutively activated in T cells develop lymphoma
1B. Correctly targeted clones were transiently transfected with
and autoimmune disease characterized by a defect in pMC1-Cre (Gu et al., 1993) to delete the loxP-flanked pGK-Hygr
Fas-mediated apoptosis (M.J. Parsons, personal com- gene. Progeny clones that became sensitive to hygromycin were
munication). Interestingly, thymic selection is not im- subjected to Southern blot analysis to detect those retaining exons
4 and 5 flanked by two loxP sites (the Ptenflox allele) and thosepaired in these animals (Jones et al., 2000), suggesting
lacking exons 4 and 5 (PtenD allele; equivalent to a knockout muta-that the onset of autoimmune disease in Ptenflox/2 mice
tion). Five Ptenflox/1 ES clones were microinjected into C57BL/6 blas-may not necessarily be related to their defect in thymic
tocysts to generate chimeric mice. Three chimeric mice successfully
negative selection. Indeed, most of the other pheno- transmitted the mutation to the germline.
types in the T cell-specific Pten-deficient mice can be To generate T cell-specific Pten-deficient mice, chimeric mice
explained by inappropriate activation of the PI3K/MAPK were backcrossed three times to C57BL6/J mice to give Ptenflox/1
mice. Ptenflox/1 mice were mated to Lck-CrePten1/2 mice (C57BL6/Jand PI3K/PKB/Akt pathways. It may be that the dramatic
background) which both carried the Lck-Cre transgene (Hennet etoncogenesis observed in Pten-deficient animals is due
al., 1995) and were heterozygous for the knockout Pten null mutationto perturbations of signaling pathways other than the
(Suzuki et al., 1998). Offspring carrying Lck-Cre and the floxed Pten
PI3K pathway that accelerate the onset of lymphoma. mutation (Lck-CrePtenflox/2), Lck-Cre and Ptenflox/1 (Lck-CrePtenflox/1),
and Lck-Cre and the wild-type Pten gene (Lck-CrePten1/1) were
used for analysis as homozygous mutant, heterozygous mutant,Role for PTEN in Linking Autoimmunity and Cancer?
and wild-type mice, respectively. Lck-CrePtenflox/2 mice were chosenIn humans, germinal mutations in the PTEN gene cause
rather than Lck-CrePtenflox/flox animals to maximize the efficiency ofBannayan-Riley-Ruvalcaba syndrome, an oncogenic gene targeting. Lck-CrePtenflox/2 mice suffering from lymphomas
disorder frequently accompanied by Hashimoto thyroid- could be distinguished by the presence of abnormally large cells,
itis, an autoimmune disease (Marsh et al., 1999). A com- an overabundance of CD41 cells, and a marked reduction in B cells,
as determined by flow cytometry. These animals were excludedmon characteristic in syndromes arising from PTEN
from the analyses.germline mutations is hamartomatous disease, in which
For thymic selection assays, HY-TCR transgenic Lck-CrePtenflox/2abnormal stromal elements, such as mesenchymal or
mice were generated. Lck-CrePtenflox/1 mice (H-2b) were crossed toinflammatory cells, influence surrounding cells to be-
HYPten1/2 mice (H-2b) heterozygous for the Pten null mutation and
come malignant. This phenomenon, termed the “land- carrying the TCR (Va3Vb8.2) transgene reactive with the male-spe-
scaper’s effect,” has been observed in disorders such cific antigen HY (Teh et al., 1988). Thymocyte and spleen populations
in negatively selecting (male) and positively selecting (female) miceas juvenile polyposis syndrome (Kinzler and Vogelstein,
were analyzed.1998). It is possible that Pten deficiency promotes the
accumulation of T cells that can mediate a landscaper’s
PCR Analysis of Pten Genotypeseffect leading to malignancy.
Genomic DNA from mouse tails was isolated and amplified by PCR,While numerous studies have shown that a history of
following a published protocol (Suzuki et al., 1998). Sense primer
autoimmune disease increases the risk of cancer (Volk- (59-GTCACCAGGATGCTTCTGAC-39) and antisense primer (59-GAA
ers, 1999), the molecules linking autoimmune disease ACGGCCTTAACGACGTAG-39) were used to detect the Ptenflox al-
to cancer are unknown. We have shown here that Pten- lele, sense primer (59-CCTTGCTCCTGCCGAGAAAGT-39) and anti-
sense primer (59-AAAGCACGAGGAAGCGGTCAG-39) were used todeficient mice, which develop T cell lymphomas, exhibit
detect the neo allele, and sense primer (59-CCTTGGTGGAGGAGGGdefects in central and peripheral tolerance. We continue
TGGAAT-39) and antisense primer (59-CCGTCAGTACGTGAGAto explore the role of impaired central tolerance in the
TATC-39) were used to detect the Lck-Cre transgene. Amplified
manifestation of autoimmunity in these animals. Further fragments of 512 bp, 413 bp, and about 900 bp, respectively, were
experimentation may well show that PTEN is a key link obtained.
between autoimmunity and tumorigenesis.
Genomic Southern Blot, Western Blots, and Akt Kinase Assay
Genomic Southern blots were performed as described (Suzuki et al.,Experimental Procedures
1998). The probe used is shown in Figure 1A. For protein analyses,
thymocytes or peripheral T cells (2 3 107) purified by Thy1.2 mag-Construction of the Targeting Vector
The conditional targeting vector (shown in Figure 1A) was con- netic beads (Macs; Miltenyi Biotec Gmbh) were stimulated with im-
mobilized anti-CD3e (10 mg/ml) and anti-CD28 (10 mg/ml) mAbs and/structed to delete a genomic fragment containing exons 4 and 5 of
the Pten gene by homologous recombination. Exon 5 encodes the or IL-2 (100 u/ml). Western blots using 50 mg of lysate protein were
performed as described (Suzuki et al., 1998). Antibodies directedphosphatase domain essential for Pten-mediated dephosphoryla-
tion of PIP3 and tumor suppressor function. One loxP site was against the N-terminal end of Pten and anti-IkBa, anti-c-myc (c-8)
were from Santa Cruz; anti-phospho-PKB/Akt (S473, Thr308), anti-introduced into intron 3 and two into intron 5, such that Pten exons
4 and 5 were flanked by the intron 3 and one intron 5 loxP sites. phospho-Bad (Ser112, 136), anti-phospho-p38 MAPK (Thr180/
Tyr182), and anti-phospho-p44/42 MAPK (T202/Y204) were fromThe hygromycin resistance gene (Hygr) fused to the phosphoglycer-
okinase (PGK) promotor (pGK-HYGr) was inserted in antisense orien- New England Biolabs; and anti-Bcl-XL and anti-P27kip1 were from
Transduction Laboratories; anti-Bcl-2 was from Upstate Biotechnol-tation between the two loxP sites in intron 5. The 960 bp genomic
fragment 59 upstream of exon 4 and the 11.9 kb ApaI-ApaI fragment ogy. The PKB/Akt kinase activity assay was performed as described
(Okano et al., 2000).39 of exon 5 were inserted as the short and long arms, respectively.
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Serum Immunoglobulin Determinations the National Cancer Institute of Canada (NCIC), and the Canadian
Breast Cancer Research Institute (CBCRI).and Anti-ssDNA Antibodies
Concentrations of serum Ig isotypes were determined by ELISA as
described (Kaisho et al., 1997). The measurement of serum anti- Received August 18, 2000; revised March 13, 2001.
ssDNA IgG antibodies was performed using ELISA as described
(Satoh et al., 1995). References
Flow Cytometric Analysis Borlado, L.R., Redondo, C., Alvarez, B., Jimenez, C., Criado, L.M.,
The following monoclonal antibodies were used: anti-CD4 (FITC- or Flores, J., Marcos, M.A., Martinez, A.C., Balomenos, D., and Carrera,
PE-conjugated), anti-CD8-PE, anti-Thy1.2-FITC, anti-B220-PE, anti- A.C. (2000). Increased phosphoinositide 3-kinase activity induces a
Vb8.1/8.2-FITC, anti-Vb6-FITC, and anti-CD69-PE (all from Phar- lymphoproliferative disorder and contributes to tumor generation in
Mingen). Stained cells were analyzed with a FACSCalibur (Becton- vivo. FASEB J. 14, 895–903.
Dickinson).
Briere, F., Servet-Delprat, C., Bridon, J.M., Saint-Remy, J.M., and
Banchereau, J. (1994). Human interleukin 10 induces naive surface
T Cell Proliferation, MLR, and Cytokine Production immunoglobulin D1 (sIgD1) B cells to secrete IgG1 and IgG3. J.
T cells were purified from MLN using Thy1.2 magnetic beads (Macs; Exp. Med. 179, 757–762.
Miltenyi Biotec Gmbh) according to the manufacturer’s instructions.
Datta, S.R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., andPurified T cells (1 3 105) were placed into round-bottomed 96-well
Greenberg, M.E. (1997). Akt phosphorylation of BAD couples sur-plates in RPMI 1640 medium containing 10% FCS. Optimal concen-
vival signals to the cell-intrinsic death machinery. Cell 91, 231–241.trations (determined in pilot assays) of soluble anti-CD3e (3 mg/ml),
del Peso, L., Gonzalez-Garcia, M., Page, C., Herrera, R., and Nunez,anti-CD28 (10 mg/ml), IL-2 (100 U/ml), Concanavalin A (ConA; 5
G. (1997). Interleukin-3 induces phosphorylation of BAD through themg/ml), or PMA (12.5 ng/ml) plus calcium ionophore (250 ng/ml)
protein kinase AKT. Science 278, 687–689.were added. T cells were harvested on day 2, after a 12 hr pulse
with 1 mCi [3H]thymidine (Amersham) per well. For MLR, lymph node Di Cristofano, A., Pesce, B., Cordon-Cardo, C., and Pandolfi, P.P.
T cells (5 3 105) from 6- to 8-week-old Ptenflox/2 and Pten1/1 mice (1998). Pten is essential for embryonic development and tumour
were incubated with 5 3 105 g irradiated (20 Gy) spleen cells from suppression. Nat. Genet. 19, 348–355.
syngeneic (C57BL6/J) or allogeneic (DBA1) mice. Cells were har- Di Cristofano, A., Kotsi, P., Peng, Y.F., Cordon-Cardo, C., Elkon,
vested on day 2, and thymidine uptake was assessed as described K.B., and Pandolfi, P.P. (1999). Impaired Fas response and autoim-
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Esser, C., and Radbruch, A. (1989). Rapid induction of transcriptionIL-4, IL-6, and IL-10 by ELISA according to the manufacturer’s (Gen-
of unrearranged S gamma 1 switch regions in activated murine Bzyme) instructions.
cells by interleukin 4. EMBO J. 8, 483–488.
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